Genmab receives $40M milestone payment in AbbVie collaboration

Jan. 13, 2021 9:32 AM ETGenmab A/S (GMAB)GMABBy: Khyathi Dalal, SA News Editor1 Comment
  • Genmab (GMAB) reached the first milestone in its collaboration with AbbVie with a $40M milestone payment triggered by the first patient dosed in the Phase 3 study of subcutaneous epcoritamab versus investigator's choice of chemotherapy in patients with relapsed or

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.